TScan Therapeutics, a publicly traded clinical-stage biotech company based outside Boston, collaborated with our agency to develop a new website that reflects its clinical and strategic focus. Its new web presence features a modern, simple design, improved usability, and clear scientific messaging.
TScan Therapeutics has gone through a significant strategic transformation. The company increased its clinical focus, streamlined its pipeline, and advanced toward key clinical milestones, but the website still reflected an earlier stage of its journey.
As a clinical-stage biotechnology company that develops engineered T cell receptor (TCR) therapies for cancer, TScan needed a digital presence that could communicate both scientific and real-world patient impact. While the science was compelling, the story lacked a cohesive structure that connected the company’s platform, pipeline, and progress in a way that investors, physicians, and patients could quickly understand.
The existing website didn’t showcase the complete momentum the company had built. Scientific differentiation, clinical advancement, and long-term vision were represented, but the narrative was difficult to absorb. For investors evaluating the opportunity, physicians looking to understand the science, and patients seeking hope, the experience lacked clarity and an emotional connection.
With important clinical milestones ahead and a need to communicate its direction, TScan needed to redesign its website to better reflect the company it is today and where it is headed.